NDAQ
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025,...
Read moreDetails
Can a $50,000 Investment in the Nasdaq-100 Today Turn Into $1 Million by the Time You Retire?
Investors will find many of the best growth stocks in the world on the Nasdaq exchange. An even more exclusive...
Read moreDetails
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing...
Read moreDetails
S&P 500 Forecast: Broad Market Edges Higher, But Qualcomm and Arm Weigh on Nasdaq 100
S&P 500 edges higher as earnings take focus, but Qualcomm and Arm drag Nasdaq 100 lower. Traders eye job data...
Read moreDetails
Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
GARDEN CITY, N.Y., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a...
Read moreDetails
Nuvini Regains Compliance with Nasdaq Listing Rule 5250(c)(2)
NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer...
Read moreDetails
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
60 Degrees Pharma (SXTP) announces a $1.075M registered direct offering, issuing stock and warrants to fund working capital and corporate...
Read moreDetails
Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
HANOVER, Md, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical...
Read moreDetails
Nasdaq 100: Apple Falls 1.6% After Hours as iPhone Sales Miss Raises Concerns
Apple beats earnings but misses iPhone sales, sending shares down 1.6% after hours. China revenue drops 11%—what's next for AAPL?
Read moreDetails
Nasdaq Dips 3% As Nvidia, Other Chip Stocks Tumble: Investor Sentiment Declines, Greed Index Moves To ‘Fear’ Zone
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to...
Read moreDetails